Fulgent Genetics Soars in January as GenomeWeb Index Begins 2021 up 10 Percent

NEW YORK – The GenomeWeb Index rose 10 percent in January, starting 2021 as it ended 2020 — on an upswing.

The index outperformed the Dow Jones Industrial Average, the Nasdaq, and the Nasdaq Biotechnology Index, which fell 2 percent, rose 1 percent, and rose 6 percent, respectively, in January. Individual stock performances in the GenomeWeb Index were largely positive last month, as 31 of the 37 stocks saw gains and only six saw losses.